Marshall Wace, LLP Ptc Therapeutics, Inc. Transaction History

Marshall Wace, LLP

  • $74.4 Billion
  • Q1 2025

A detailed history of Marshall Wace, LLP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 741,002 shares of PTCT stock, worth $34 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
741,002
Holding current value
$34 Million
% of portfolio
0.05%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$41.81 - $57.17 $31 Million - $42.4 Million
741,002 New
741,002 $37.8 Million
Q2 2024

Aug 14, 2024
BUY
$24.69 - $40.12 $3.89 Million - $6.32 Million
157,460 Added 708.67%
179,679 $5.49 Million
Q1 2024

May 15, 2024
BUY
$24.15 - $31.95 $536,588 - $709,897
22,219 New
22,219 $646,000
Q2 2023

Aug 14, 2023
BUY
$40.4 - $59.1 $249,752 - $365,356
6,182 New
6,182 $251,000
Q1 2022

May 16, 2022
SELL
$33.33 - $44.6 $201,379 - $269,473
-6,042 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$37.95 - $49.37 $1.37 Million - $1.79 Million
-36,215 Reduced 85.7%
6,042 $255,000
Q1 2021

May 17, 2021
BUY
$46.8 - $68.92 $1.98 Million - $2.91 Million
42,257 New
42,257 $2 Million
Q4 2020

Feb 16, 2021
SELL
$47.96 - $67.64 $1.43 Million - $2.02 Million
-29,800 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$45.41 - $57.07 $216,878 - $272,566
-4,776 Reduced 13.81%
29,800 $1.39 Million
Q2 2020

Aug 13, 2020
BUY
$42.56 - $54.98 $1.47 Million - $1.9 Million
34,576 New
34,576 $1.75 Million
Q1 2020

May 15, 2020
SELL
$32.37 - $59.36 $861,527 - $1.58 Million
-26,615 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$32.22 - $50.07 $6.7 Million - $10.4 Million
-207,941 Reduced 88.65%
26,615 $1.28 Million
Q3 2019

Nov 14, 2019
BUY
$33.82 - $48.17 $7.93 Million - $11.3 Million
234,556 New
234,556 $7.93 Million
Q1 2019

May 14, 2019
SELL
$28.09 - $39.49 $720,002 - $1.01 Million
-25,632 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$29.83 - $46.51 $764,602 - $1.19 Million
25,632 New
25,632 $880,000
Q3 2018

Nov 14, 2018
SELL
$33.9 - $47.77 $687,424 - $968,680
-20,278 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$25.7 - $47.88 $521,144 - $970,910
20,278 New
20,278 $684,000

Others Institutions Holding PTCT

# of Institutions
283
Shares Held
78.5M
Call Options Held
223K
Put Options Held
156K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.29B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email